Straits Times Index
3,298.92 +12.59 (+0.38%) S&P 500
4,210.24 +87.77 (+2.13%) Dow
33,309.51 +535.11 (+1.63%) Nasdaq
12,854.80 +360.88 (+2.89%) BTC-USD
24,473.60 +1,391.09 (+6.03%) CMC Crypto 200
576.19 +44.97 (+8.47%)
LLY Jan 2024 250.000 call
| Previous close | 76.20 |
| Open | 76.20 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 250.00 |
| Expiry date | 2024-01-19 |
| Day's range | 76.20 - 76.20 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
- Yahoo Finance Video
Eli Lilly and Cummins speak out against Indiana's new abortion ban
Yahoo Finance senior columnist Rick Newman highlights the corporate backlash Indiana lawmakers are receiving after signing a new abortion ban into law.
- Financial Times
Eli Lilly says Indiana abortion ban will shift jobs out of its home state
Eli Lilly said it would divert employment outside its home state of Indiana following the Republican-controlled legislature’s decision to pass a nearly total ban on abortion. “We are concerned that this law will hinder Lilly’s — and Indiana’s — ability to attract diverse scientific, engineering and business talent from around the world,” said Lilly. The US drugmaker said it had expanded its employee health plan to cover interstate travel for abortion and reproductive services, but added this might not be enough for some current and future staff.
- Zacks
Nektar's (NKTR) Q2 Earnings and Revenues Miss Estimates
Nektar (NKTR) reports dismal second-quarter 2022 results. The company's operating expenses increased due to restructuring expenses of $106.0 million incurred during the quarter.
